ArticleChemistryOpen2022
MIL-100(Fe) Supported Pt-Co Nanoparticles as Active and Selective Heterogeneous Catalysts for Hydrogenation of 1,3-Butadiene.
Article in ChemistryOpen, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Mesoporous Silica-Supported MOF Composites for CONanomaterials (Basel, Switzerland) · 2026Review
- Carboxylate-Ligand-Based Coordination Polymers and Metal Complexes: From Structural Diversity and Supramolecular Descriptors to Function-Oriented Design.Molecules (Basel, Switzerland) · 2026Review
- Heterojunction Engineering of Electrodes and Membranes in Redox Flow Batteries.Chemical record (New York, N.Y.) · 2026Review
- Bimetallic Au-Ru nanoparticles supported on zeolitic imidazolate framework-67 as highly efficient catalysts for the selective oxidation of benzyl alcohol.Scientific reports · 2025Article
- MIL-53(Al)-derived bimetallic Pd-Co catalysts for the selective hydrogenation of 1,3-butadiene at low temperature.Scientific reports · 2025Article
- MOF-Derived ZrOMolecules (Basel, Switzerland) · 2024Article
- Efficient oxidation of benzyl alcohol into benzaldehyde catalyzed by graphene oxide and reduced graphene oxide supported bimetallic Au-Sn catalysts.RSC advances · 2023Article
- MIL-100(Fe) Supported Pt-Co Nanoparticles as Active and Selective Heterogeneous Catalysts for Hydrogenation of 1,3-Butadiene.ChemistryOpen · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Superior catalytic performance for selective 1,3-butadiene (1,3-BD) hydrogenation can usually be achieved with supported bimetallic catalysts. In this work, Pt-Co nanoparticles and Pt nanoparticles supported on metal-organic framework MIL-100(Fe) catalysts (MIL=Materials of Institut Lavoisier, PtCo/MIL-100(Fe) and Pt/MIL-100(Fe)) were synthesized via a simple impregnation reduction method, and their catalytic performance was investigated for the hydrogenation of 1,3-BD. Pt1Co1/MIL-100(Fe) presented better catalytic performance than Pt/MIL-100(Fe), with significantly enhanced total butene selectivity. Moreover, the secondary hydrogenation of butenes was effectively inhibited after doping with Co. The Pt1Co1/MIL-100(Fe) catalyst displayed good stability in the 1,3-BD hydrogenation reaction. No significant catalyst deactivation was observed during 9 h of hydrogenation, but its catalytic activity gradually reduces for the next 17 h. Carbon deposition on Pt1Co1/MIL-100(Fe) is the reason for its deactivation in 1,3-BD hydrogenation reaction. The spent Pt1Co1/MIL-100(Fe) catalyst could be regenerated at 200 °C, and regenerated catalysts displayed the similar 1,3-BD conversion and butene selectivity with fresh catalysts. Moreover, the rate-determining step of this reaction was hydrogen dissociation. The outstanding activity and total butene selectivity of the Pt1Co1/MIL-100(Fe) catalyst illustrate that Pt-Co bimetallic catalysts are an ideal alternative for replacing mono-noble-metal-based catalysts in selective 1,3-BD hydrogenation reactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.